These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 14642968

  • 1. Half a century of antipsychotics and still a central role for dopamine D2 receptors.
    Kapur S, Mamo D.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1081-90. PubMed ID: 14642968
    [Abstract] [Full Text] [Related]

  • 2. Atypical antipsychotics: mechanism of action.
    Seeman P.
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [Abstract] [Full Text] [Related]

  • 3. Potential role of 5-HT2 and D2 receptor interaction in the atypical antipsychotic action of the novel succimide derivative, perospirone.
    Ohno Y, Ishida-Tokuda K, Ishibashi T, Sakamoto H, Tagashira R, Horisawa T, Yabuuti K, Matsumoto K, Kawabe A, Nakamura M.
    Pol J Pharmacol; 1997 Aug; 49(4):213-9. PubMed ID: 9437764
    [Abstract] [Full Text] [Related]

  • 4. The differential effects of atypical antipsychotics on prolactin elevation are explained by their differential blood-brain disposition: a pharmacological analysis in rats.
    Kapur S, Langlois X, Vinken P, Megens AA, De Coster R, Andrews JS.
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1129-34. PubMed ID: 12183672
    [Abstract] [Full Text] [Related]

  • 5. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs.
    Miyamoto S, Duncan GE, Marx CE, Lieberman JA.
    Mol Psychiatry; 2005 Jan; 10(1):79-104. PubMed ID: 15289815
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological profiles in rats of novel antipsychotics with combined dopamine D2/serotonin 5-HT1A activity: comparison with typical and atypical conventional antipsychotics.
    Bardin L, Auclair A, Kleven MS, Prinssen EP, Koek W, Newman-Tancredi A, Depoortère R.
    Behav Pharmacol; 2007 Mar; 18(2):103-18. PubMed ID: 17351418
    [Abstract] [Full Text] [Related]

  • 7. Induction patterns of transcription factors of the nur family (nurr1, nur77, and nor-1) by typical and atypical antipsychotics in the mouse brain: implication for their mechanism of action.
    Maheux J, Ethier I, Rouillard C, Lévesque D.
    J Pharmacol Exp Ther; 2005 Apr; 313(1):460-73. PubMed ID: 15615863
    [Abstract] [Full Text] [Related]

  • 8. [Pharmacology of second-generation antipsychotics: a validity of the serotonin-dopamine hypothesis].
    Kuroki T.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Oct; 24(5):257-64. PubMed ID: 15658501
    [Abstract] [Full Text] [Related]

  • 9. Receptor mechanisms in the treatment of schizophrenia.
    Reynolds GP.
    J Psychopharmacol; 2004 Sep; 18(3):340-5. PubMed ID: 15358977
    [Abstract] [Full Text] [Related]

  • 10. [Receptor occupancy and antipsychotic drug action measured by PET and SPECT].
    Okubo Y, Suhara T.
    Seishin Shinkeigaku Zasshi; 2001 Sep; 103(4):329-40. PubMed ID: 11392846
    [Abstract] [Full Text] [Related]

  • 11. Theoretical insights into the mechanism of action of atypical antipsychotics.
    Tort AB, Souza DO, Lara DR.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):541-8. PubMed ID: 16458403
    [Abstract] [Full Text] [Related]

  • 12. Serotonin receptors: their key role in drugs to treat schizophrenia.
    Meltzer HY, Li Z, Kaneda Y, Ichikawa J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1159-72. PubMed ID: 14642974
    [Abstract] [Full Text] [Related]

  • 13. [Critical review of mechanisms of action of second-generation antipsychotic drugs].
    Miyamoto S.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Nov; 26(5-6):199-208. PubMed ID: 17240845
    [Abstract] [Full Text] [Related]

  • 14. Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action.
    Kapur S, Seeman P.
    J Psychiatry Neurosci; 2000 Mar; 25(2):161-6. PubMed ID: 10740989
    [Abstract] [Full Text] [Related]

  • 15. Atypical and typical antipsychotic drug interactions with the dopamine D2 receptor.
    Hjerde E, Dahl SG, Sylte I.
    Eur J Med Chem; 2005 Feb; 40(2):185-94. PubMed ID: 15694653
    [Abstract] [Full Text] [Related]

  • 16. [Functional role of dopamine D3 receptor in schizophrenia].
    Semba J.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Feb; 24(1):3-11. PubMed ID: 15027325
    [Abstract] [Full Text] [Related]

  • 17. Antipsychotics--history of development and field of indication, new wine--old glassess.
    Jašović-Gašić M, Vuković O, Pantović M, Cvetić T, Marić-Bojović N.
    Psychiatr Danub; 2012 Oct; 24 Suppl 3():S342-4. PubMed ID: 23114814
    [Abstract] [Full Text] [Related]

  • 18. Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes.
    Moran-Gates T, Massari C, Graulich A, Liégeois JF, Tarazi FI.
    J Neurosci Res; 2006 Aug 15; 84(3):675-82. PubMed ID: 16810690
    [Abstract] [Full Text] [Related]

  • 19. [Does 'selective binding profile' result in 'selective treatment'?].
    Suzuki T.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2001 Feb 15; 21(1):1-5. PubMed ID: 11400320
    [Abstract] [Full Text] [Related]

  • 20. [The mechanisms of action of antipsychotic drugs: is atypicality superior in schizophrenia treatment?].
    Anil Yağcioğlu AE.
    Turk Psikiyatri Derg; 2007 Feb 15; 18(4):364-74. PubMed ID: 18066727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.